Cargando…

What Are the Main Differences in the Treatment of Chronic Hepatitis B between Korean Children and Adults?

Detalles Bibliográficos
Autor principal:	Choe, Byung-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809755/ https://www.ncbi.nlm.nih.gov/pubmed/29441758 http://dx.doi.org/10.3346/jkms.2018.33.e69

Ejemplares similares

A disappearing vertical infection: will hepatitis B be a forgotten disease in children?
por: Choe, Byung-Ho
Publicado: (2014)

Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era
por: Hong, Suk-Jin, et al.
Publicado: (2020)

Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
por: Kang, Ben, et al.
Publicado: (2022)

Differences in Features and Course of Mucosal Type Eosinophilic Gastroenteritis between Korean Infants and Children
por: Choi, Bong Seok, et al.
Publicado: (2015)

Lamivudine Therapy for Korean Children with Chronic Hepatitis B
por: Koh, Hong, et al.
Publicado: (2007)

Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B
por: Choe, Jae Young, et al.
Publicado: (2017)

What's New in the Korean Journal of Radiology in 2021
por: Park, Seong Ho
Publicado: (2021)

Current Role of Lamivudine Regarding Therapeutic Response and Resistance in Children with Chronic Hepatitis B
por: Hong, Suk Jin, et al.
Publicado: (2013)

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
por: Jung, Young Kul, et al.
Publicado: (2013)

Safety and Competency are the Main Priorities in Pediatric Endoscopy
por: Choe, Byung-Ho
Publicado: (2020)

Gender and age differences in obesity among Korean adults
por: Kang, Jun Goo, et al.
Publicado: (2013)

Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
por: Lee, Hyun Woong
Publicado: (2020)

Chronic Kidney Disease and Hepatitis B Virus Surface Antigenemia
por: Lee, Sung Woo, et al.
Publicado: (2018)

The Different Features of Inflammatory Endotypes in Korean Patients With Chronic Rhinosinusitis
por: Yoo, Shin Hyuk, et al.
Publicado: (2023)

How to compare antivirals in the treatment of chronic hepatitis B?
por: Ozaras, Resat, et al.
Publicado: (2009)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2014)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2016)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2015)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2017)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2018)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2019)

Thanks to the Reviewers of the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2020)

The Rate of Conversion from Immune-tolerant Phase to Early Immune-clearance Phase in Children with Chronic Hepatitis B Virus Infection
por: Hong, Suk Jin, et al.
Publicado: (2014)

Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
por: Adinolfi, Luigi Elio, et al.
Publicado: (2018)

Announcement of New Editor-in-Chief for the Korean Journal of Radiology
por: Choe, Yeon Hyeon
Publicado: (2020)

Development of Korean Rome III Questionnaire: What Will We Do With Korean Rome III Questionnaire?
por: Cho, Yu Kyung
Publicado: (2013)

On the future of therapeutic vaccination in chronic hepatitis B
por: Aguilar Rubido, Julio Cesar
Publicado: (2019)

Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
por: Choi, Jonggi
Publicado: (2023)

Characterization of the fecal microbiota differs between age groups in Koreans
por: Kook, Sun-Young, et al.
Publicado: (2018)

Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
por: Yeon, Jong Eun
Publicado: (2018)

A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
por: Schierwagen, Robert, et al.
Publicado: (2020)

Community-acquired pneumonia in Korean children: time to read between the lines
por: Suh, Dong In
Publicado: (2022)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
por: Kim, Jin-Wook
Publicado: (2019)

Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
por: Shim, Jae-Jun, et al.
Publicado: (2016)

What Does the Korean Medical Association Need to Talk About?
por: Park, Hyoung Wook
Publicado: (2014)

What Are the Major Changes in Korean Inflammatory Bowel Disease Surgery?
por: Kim, Chang-Nam
Publicado: (2018)

Korean Valve Survey: Is This Just the Beginning? What Is the Next Step?
por: Lee, Seonhwa, et al.
Publicado: (2023)

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
por: Chun, Ho Soo, et al.
Publicado: (2021)

Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
por: Kim, Ji Hoon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lk02uohuksbr7g31djn5hd35o4